Literature DB >> 8880606

Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8880606

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN： 0888-0395            Impact factor:   1.230


× No keyword cloud information.
  2 in total

1.  Aspirin use associated with amyotrophic lateral sclerosis: a total population-based case-control study.

Authors:  Ching-Piao Tsai; Feng-Cheng Lin; Johnny Kuang-Wu Lee; Charles Tzu-Chi Lee
Journal:  J Epidemiol       Date:  2014-12-27       Impact factor: 3.211

2.  Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan.

Authors:  Charles Tzu-Chi Lee; Yi-Wen Chiu; Kai-Chen Wang; Chi-Shin Hwang; Kuan-Hsiang Lin; I-Ta Lee; Ching-Piao Tsai
Journal:  J Epidemiol       Date:  2012-10-27       Impact factor: 3.211
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.